Cargando…
Effect of Intensive Glycemic and Blood Pressure Control on QT Prolongation in Diabetes: The ACCORD Trial
Compared with standard glycemic control, intensive glycemic control caused increased mortality in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Preliminary data from several studies suggest that intensive glycemic control is associated with QT prolongation, which may lead to...
Autores principales: | Singleton, Matthew J., Soliman, Elsayed Z., Bertoni, Alain G., Whalen, S. Patrick, Bhave, Prashant D., Yeboah, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809716/ https://www.ncbi.nlm.nih.gov/pubmed/32732305 http://dx.doi.org/10.2337/db20-0401 |
Ejemplares similares
-
Association of Alcohol Intake With Hypertension in Type 2 Diabetes Mellitus: The ACCORD Trial
por: Mayl, Jonathan J., et al.
Publicado: (2020) -
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies
por: Ali, Ali Mohamed, et al.
Publicado: (2023) -
Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with Tuberculosis
por: Li, Hanbin, et al.
Publicado: (2019) -
Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023) -
A Fully Human, Allosteric Monoclonal Antibody That Activates the Insulin Receptor and Improves Glycemic Control
por: Bhaskar, Vinay, et al.
Publicado: (2012)